Localised Mycobacterium ulcerans infection in four dogs

Australian Veterinary Journal

Volumn 89, Issue 12, 2011, Pages 506-510

  O'Brien, C R ^a   McMillan, E ^b   Harris, O ^c   O'Brien, D P ^d   Lavender, C J ^e   Globan, M ^e   Legione, A R ^a   Fyfe, J A ^e  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Bellarine Veterinary Hospital   (Australia)

^c St John of God Pathology   (Australia)

^d GEELONG HOSPITAL   (Australia)

^e VICTORIAN INFECTIOUS DISEASES REFERENCE LABORATORY   (Australia)

Author keywords

Bairnsdale ulcer; Buruli ulcer; Dogs; Mycobacterium ulcerans

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL DNA;

ANIMAL; ANIMAL DISEASE; ARTICLE; BURULI ULCER; CASE REPORT; DOG; DOG DISEASE; FEMALE; GENETICS; ISOLATION AND PURIFICATION; MALE; MULTIMODALITY CANCER THERAPY; MYCOBACTERIUM ULCERANS; TREATMENT OUTCOME;

ANIMALS; ANTI-BACTERIAL AGENTS; BURULI ULCER; COMBINED MODALITY THERAPY; DNA, BACTERIAL; DOG DISEASES; DOGS; FEMALE; MALE; MYCOBACTERIUM ULCERANS; TREATMENT OUTCOME;

EID: 82055184999     PISSN: 00050423     EISSN: 17510813     Source Type: Journal    
DOI: 10.1111/j.1751-0813.2011.00850.x     Document Type: Article

References (35)

1. Yip MJ, Porter JL, Fyfe JA etal. Evolution of Mycobacterium ulcerans and other mycolactone-producing mycobacteria from a common Mycobacterium marinum progenitor. J Bacteriol 2007;189:2021-2029.
2. Stinear TP, Jenkin GA, Johnson PD, Davies JK. Comparative genetic analysis of Mycobacterium ulcerans and Mycobacterium marinum reveals evidence of recent divergence. J Bacteriol 2000;182:6322-6330.
3. Stinear TP, Mve-Obiang A, Small PL etal. Giant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans. Proc Natl Acad Sci USA 2004;101:1345-1349.
4. George KM, Chatterjee D, Gunawardana G etal. Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science 1999;283:854-857.
5. Johnson PD, Stinear T, Small PL etal. Buruli ulcer (M. ulcerans infection): new insights, new hope for disease control. PLoS Med 2005;2:108.
6. Johnson PD, Veitch MG, Leslie DE, Flood PE, Hayman JA. The emergence of Mycobacterium ulcerans infection near Melbourne. Med J Aust 1996;164:76-78.
7. O'Brien DP, Hughes AJ, Cheng AC etal. Improved outcomes for Mycobacterium ulcerans infection with combined surgery and antibiotic therapy: findings from a south-eastern Australian case series. Med J Aust 2007;186:58-61.
8. Jenkin GA, Smith M, Fairley M, Johnson PD. Acute, oedematous Mycobacterium ulcerans infection in a farmer from far north Queensland. Med J Aust 2002;176:180-181.
9. Steffen CM, Smith M, McBride WJH. Mycobacterium ulcerans infection in North Queensland: the 'Daintree ulcer'. Aust NZ J Surg 2010;80:732-736.
10. Francis G, Whitby M, Woods M. Mycobacterium ulcerans infection: a rediscovered focus in the Capricorn Coast region of central Queensland. Med J Aust 2006;185:179-180.
11. Alsop DG. The Bairnsdale ulcer. Aust NZ J Med 1972;41:317-319.
12. MacCallum P, Tolhurst JC, Buckle G, Sissons HA. A new mycobacterial infection in man. J Pathol Bacteriol 1948;60:93-122.
13. McOrist S, Jerrett IV, Anderson M, Hayman J. Cutaneous and respiratory tract infection with Mycobacterium ulcerans in two koalas (Phascolarctos cinereus). J Wildl Dis 1985;21:171-173.
14. Mitchell PJ, McOrist S, Bilney R. Epidemiology of Mycobacterium ulcerans infection in koalas (Phascolarctos cinereus) on Raymond Island, south-eastern Australia. J Wildl Dis 1987;23:386-390.
15. Mitchell PJ, Jerrett IV, Slee KJ. Skin ulcers caused by Mycobacterium ulcerans in koalas near Bairnsdale, Australia. Pathology 1984;16:256-260.
16. Portaels F, Chemlal K, Elsen P etal. Mycobacterium ulcerans in wild animals. Rev Sci Tech 2001;20:252-264.
17. Elsner L, Wayne J, O'Brien CR etal. Localised Mycobacterium ulcerans infection in a cat in Australia. J Feline Med Surg 2008;10:407-412.
18. Fyfe JAM, Lavender CJ, Handasyde KA etal. A major role for mammals in the ecology of Mycobacterium ulcerans. PLoS Negl Trop Dis 2010;4:791.
19. van Zyl A, Daniel J, Wayne J etal. Mycobacterium ulcerans infections in two horses in south-eastern Australia. Aust Vet J 2010;88:101-106.
20. Editorial: Mycobacterium ulcerans in Australia. Med J Aust 1975;2:660-661.
21. Clancey JK. Mycobacterial skin ulcers in Uganda; description of a new mycobacterium (Mycobacterium buruli). J Pathol Bacteriol 1964;88:175-187.
22. Marcus LC, Stottmeier KD, Morrow RH. Experimental infection of anole lizards (Anolis carolinensis) with Mycobacterium ulcerans by the subcutaneous route. Am J Trop Med Hyg 1975;24:649-655.
23. Walsh DS, Meyers WM, Krieg RE, Walsh GP. Transmission of Mycobacterium ulcerans to the nine-banded armadillo. Am J Trop Med Hyg 1999;61:694-697.
24. Fyfe JA, Lavender CJ, Johnson PD etal. Development and application of two multiplex real-time PCR assays for the detection of Mycobacterium ulcerans in clinical and environmental samples. Appl Environ Microbiol 2007;73:4733-4740.
25. Ablordey A, Swings J, Hubans C etal. Multilocus variable-number tandem repeat typing of Mycobacterium ulcerans. J Clin Microbiol 2005;43:1546-1551.
26. Portaels F. Epidemiology of mycobacterial diseases. Clin Dermatol 1995;13:207-222.
27. Johnson PD, Azuolas J, Lavender CJ etal. Mycobacterium ulcerans in mosquitoes captured during outbreak of Buruli ulcer, south-eastern Australia. Emerg Infect Dis 2007;13:1653-1660.
28. O'Brien DP, Athan E, Hughes A, Johnson PD. Successful treatment of Mycobacterium ulcerans osteomyelitis with minor surgical debridement and prolonged rifampicin and ciprofloxacin therapy: a case report. J Med Case Rep 2008;2:123.
29. Johnson PD, Hayman JA, Quek TY etal. Consensus recommendations for the diagnosis, treatment and control of Mycobacterium ulcerans infection (Bairnsdale or Buruli ulcer) in Victoria, Australia. Med J Aust 2007;186:64-68.
30. Nienhuis WA, Stienstra Y, Thompson WA etal. Antimicrobial treatment for early, limited Mycobacterium ulcerans infection: a randomised controlled trial. Lancet 2010;375:664-672.
31. Gordon CL, Buntine JA, Hayman JA etal. All-oral antibiotic treatment for Buruli ulcer: a report of four patients. PLoS Negl Trop Dis 2010;4:e770.
32. Etuaful S, Carbonnelle B, Grosset J etal. Efficacy of the combination rifampin-streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans. Antimicrob Agents Chemother 2005;49:3182-3186.
33. Chauty A, Ardant MF, Adeye A etal. Promising clinical efficacy of streptomycin-rifampin combination for treatment of buruli ulcer (Mycobacterium ulcerans disease). Antimicrob Agents Chemother 2007;51:4029-4035.
34. Malik R, Martin P, Wigney D etal. Treatment of canine leproid granuloma syndrome: preliminary findings in seven dogs. Aust Vet J 2001;79:30-36.
35. O'Brien DP, Robson ME, Callan PP, McDonald AH. 'Paradoxical' immune-mediated reactions to Mycobacterium ulcerans during antibiotic treatment: a result of treatment success, not failure. Med J Aust 2009;191:564-566.